Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Overview of attention for article published in Journal of Clinical Oncology, July 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

patent: 3 patents
guideline: 3 clinical guideline sources

Readers on

mendeley: 147 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 835 followers.

@rayovaCris @Mr_Hyde1866 É isso o que a medicina tradicional (que você defende com unhas e dentes) tem a oferecer. Explique pra ele o que aconteceu com essas pessoas do estudo @grok Qual foi a taxa de sobrevida, quantas foram curadas e a taxa de sucess…

@Magicsia This study contributes further evidence of the minimal to moderate efficacy of DOX in HCC.http://t.co/4uJBHREn

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.